Thomas Barba

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster et al. · Blood · 2022 · 194 citations · Full text

Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants

Alice Koenig, Chien‐Chia Chen, Antoine Marçais et al. · Nature Communications · 2019 · 171 citations · Full text

Cell Therapy, Immunology, Transplantation Medicine +20

Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients

Kaïs Ahmad, Thomas Barba, D. Gamondès et al. · Respiratory Medicine · 2016 · 157 citations · Full text

Rheumatology, Autoimmune Disease, Immunodeficiencies +8

VEXAS syndrome in a woman

Thomas Barba, Yvan Jamilloux, Cécile‐Audrey Durel et al. · Lara D. Veeken · 2021 · 99 citations

A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis

Maxime Espi, Xavier Charmetant, Thomas Barba et al. · Kidney International · 2021 · 83 citations · Full text

Vaccination, Vaccine Safety, Hemodialysis +10